OncBioMune
2005
FOUNDED
PUBLIC
STATUS
1
INVESTMENTS
Description
Developer of biotechnology products for cancer treatment. The company engages in marketing and distribution of hospital specialty pharmaceutical prescription products.
Website
Formerly Known As
Quint Media
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
OTC
Primary Office
- 17050 Medical Center Drive
- Baton Rouge, LA 70816
- United States
+1 (225) 000-0000
OncBioMune Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore OncBioMune‘s full profile, request access.
Request full access to PitchBookOncBioMune Competitors (43)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GlaxoSmithKline | Corporation | Brentford, United Kingdom | 000000 | 00000000000 | ||
| 000 00000 | Corporation | Indianapolis, IN | 00000 | 000000 - 000 | ||
| 00 000000000000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 000000&0 | 00000 |
| 000000000 00000000 | Private Equity-Backed | Bethesda, MD | 00 | 00000 | 000000000 | 00000 |
| 000000 | Formerly VC-backed | Waltham, MA | 000 | 00.000 | 000000&0 | 00.000 |
OncBioMune Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 000000000000 | 10-Mar-2017 | 000000000000000000 | Biotechnology | 00000000 0000 00.0 |